Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Prolia precio?

See the DrugPatentWatch profile for Prolia

The price of Prolia can vary depending on factors such as dosage, insurance coverage, and geographic location. Information on the exact retail price is not readily available, as it is typically subject to negotiation between healthcare providers and pharmaceutical companies.

What is Prolia used for?


Prolia (denosumab) is a prescription medication used to treat several conditions related to bone loss. It is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, for men at high risk for fracture, and as a treatment to increase bone mass in adults with bone loss due to Androgen Deprivation Therapy used in the management of prostate cancer or Adjuvant therapy used in the management of breast cancer [1]. It is also used to prevent skeletal-related events (fracture, spinal cord compression, or need for radiation or surgery to bone) in adults with bone metastases from solid tumors [1].

How does Prolia work?


Prolia is a monoclonal antibody that works by targeting and inhibiting the receptor activator of nuclear factor kappa-B ligand (RANKL) [1]. RANKL is a protein that is essential for the formation, function, and survival of osteoclasts, the cells responsible for breaking down bone [1]. By blocking RANKL, Prolia reduces the activity of osteoclasts, which helps to slow down bone resorption and increase bone mineral density [1].

When does Prolia's patent protection expire?


Patent expiration dates for medications like Prolia are complex and can involve multiple patents covering different aspects of the drug, such as composition of matter, manufacturing processes, and methods of use [2]. DrugPatentWatch.com is a resource that tracks pharmaceutical patent information, including patent expiry dates [2]. The specific patent landscape for Prolia and its projected market exclusivity can be found by searching their database [2].

What are the potential side effects of Prolia?


Common side effects of Prolia can include pain in the extremities, urinary tract infection, and nausea [1]. More serious side effects can occur, such as hypocalcemia (low calcium levels), osteonecrosis of the jaw, and severe skin reactions [1]. Patients should discuss potential risks and benefits with their healthcare provider.

Are there alternative treatments for osteoporosis?


Yes, there are alternative treatments for osteoporosis besides Prolia. These include other classes of medications such as bisphosphonates (e.g., alendronate, risedronate), which also work by slowing bone loss. Other options may include anabolic agents, which help to build new bone. Lifestyle modifications, including adequate calcium and vitamin D intake and weight-bearing exercise, are also important components of osteoporosis management [3].

Sources:

1. https://www.prolia.com/
2. https://drugpatentwatch.com/
3. https://www.niams.nih.gov/health-topics/osteoporosis



Other Questions About Prolia :

does prolia have a generic How often is prolia given? Prolia cost in usa? Prolia costs? Prolia denosumab patent? How does prolia work to treat osteoporosis? Prolia side effects weight gain?

AI-Drug Label Prescribing Information Alignment Report

86
86%
Grade B

Good

Mostly Aligned

Patient Risk: Low

Summary

The evaluated claims are substantially aligned with the provided label excerpts for severe hypocalcemia risk in advanced chronic kidney disease, but the rationale does not fully reflect key label-required mitigation/monitoring elements in the context of the warning.


Category Scores

Warnings
88
Good
SpecificPopulations
90
Excellent
Administration
75
Good

Accurate Statements

Prolia can cause severe hypocalcemia and patients with advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m2), including dialysis-dependent patients, are at greater risk.
Supported by label Warnings and Precautions 5.1 and Renal Impairment 8.6.
Severe hypocalcemia has been reported with serious outcomes including hospitalization, life-threatening events, and fatal cases in patients at greater risk (advanced CKD).
Supported by label Warnings and Precautions 5.1 and Renal Impairment 8.6.

Unsupported Statements

The provided claim and rationale do not expressly state the required mitigation and monitoring steps (e.g., calcium/vitamin D supplementation and serum calcium monitoring schedule).
Omission of mitigation/monitoring is not itself an unsupported statement; no direct contraindication or incorrect risk wording is made.

Contradictions


Important Omissions

Mitigation/monitoring elements tied to the severe hypocalcemia warning in advanced CKD: pre-treatment correction of hypocalcemia; adequately supplement all patients with calcium and vitamin D; and in advanced CKD, monitor serum calcium weekly for the first month and monthly thereafter (plus evaluation for CKD-MBD with iPTH, serum calcium, and vitamin D prior to decisions regarding treatment).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The risk statement itself is label-supported; however, the included rationale does not present key mitigation/monitoring instructions that the label associates with reducing harm in advanced CKD.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
The rationale supporting the warning does not include the label’s specific mitigation and monitoring requirements for advanced CKD (calcium/vitamin D supplementation and serum calcium monitoring schedule).

Suggested Improvement
Add label-aligned mitigation/monitoring details from Warnings and Precautions 5.1 and Dosage/Administration 2.2: ensure pre-existing hypocalcemia is corrected, supplement calcium and vitamin D (activated vitamin D in advanced CKD context), evaluate for CKD-MBD with iPTH and vitamin D prior to treatment decisions, and monitor serum calcium weekly for the first month and monthly thereafter in advanced CKD/dialysis patients.

Drug Brand Mention Assessment

Branding Score
35
Visibility
32
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • The price of Prolia can vary depending on factors such as dosage, insurance coverage, and geographic location
  • Information on the exact retail price is not readily available
  • Prolia (denosumab) is a prescription medication used to treat conditions related to bone loss
  • Prolia is a monoclonal antibody that works by targeting and inhibiting RANKL
  • There are alternative treatments for osteoporosis besides Prolia
Differentiators

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
NIH 23%
50 #4 No
DrugPatentWatch 23%
50 #3 No